SCHEMBL1502465

SCHEMBL1502465

COC(=O)C(C)(C)c1ccc(C(=O)CCCI)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
ALOX15 P16050 1/20 0.43
APEX1 P27695 1/20 0.43
MAPK1 P28482 1/20 0.43
RECQL P46063 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PDE4B Q07343 1/20 0.41
HDAC1 Q13547 3/20 0.40
HDAC8 Q9BY41 3/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 3/20 0.40
MAPT P10636 1/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
BRS3 P32247 1/20 0.38
HSD17B3 P37058 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
STS P08842 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12139296 0.91 ALDH1A1 (0.45) ALDH1A1LMNAALOX15APEX1MAPK1
SCHEMBL4622882 0.87 ALDH1A1 (0.44) ALDH1A1LMNAALOX15APEX1MAPK1
SCHEMBL4686360 0.85 ALDH1A1 (0.43) ALDH1A1LMNAALOX15APEX1MAPK1
SCHEMBL1502354 0.85 ALDH1A1 (0.43) ALDH1A1LMNAALOX15APEX1MAPK1
SCHEMBL1502278 0.83 NPC1 (0.42) LMNATDP1PDE4BHDAC1HDAC8
SCHEMBL4960271 0.82 KMT2A (0.53) ALDH1A1LMNAALOX15APEX1MAPK1
SCHEMBL9926017 0.81 NPC1 (0.54) ALDH1A1LMNAALOX15APEX1MAPK1
SCHEMBL28698668 0.78 ALDH1A1 (0.47) ALDH1A1LMNAALOX15APEX1MAPK1
SCHEMBL28370678 0.78 GSK3B (0.54) ALDH1A1LMNAALOX15APEX1MAPK1
SCHEMBL2763103 0.77 NPC1 (0.42) ALDH1A1LMNARECQLTDP1PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289867-A2 A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof Jubilant Organosys Limited (IN) 2011-03-02 EP disclosed
US-7863452-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
US-7863452-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
US-20090124810-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2009-05-14 US disclosed
US-20090124810-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2009-05-14 US disclosed
US-7498345-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2009-03-03 US disclosed
US-7498345-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2009-03-03 US disclosed
US-20080227983-A1 PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION AMR TECHNOLOGY, INC. (US) 2008-09-18 US disclosed
US-7390906-B2 Forming ketone intermediates to terfenadine carboxylic acid metabolite; by use of pure regioisomer of 4-(Cyclopropyl-oxo-methyl)-alpha,alpha-dimethylphenylacetic acid AMR TECHNOLOGY, INC. (US) 2008-06-24 US disclosed
US-7238834-B2 Piperidine derivatives and process for their production AMR TECHNOLOGY, INC. (US) 2007-07-03 US disclosed
EP-0703902-B1 PROCESS FOR THE PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RES INC (US) 1998-12-16 EP disclosed
US-5750703-A Piperidine derivatives and process for their production ALBANY MOLECULAR RESEARCH, INC. (US) 1998-05-12 US disclosed
US-5663412-A Aromatic ketones ALBANY MOLECULAR RESEARCH, INC. (US) 1997-09-02 US disclosed
US-5589487-A Piperidine derivatives and process for their production ALBANY MOLECULAR RESEARCH, INC. (US) 1996-12-31 US disclosed
US-5581011-A Aromatic ketones and processes for their preparation ALBANY MOLECULAR RESEARCH, INC. (US) 1996-12-03 US disclosed
US-5578610-A Piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 1996-11-26 US disclosed
EP-0723958-A1 Synthesis of substantially pure terfenadine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 1996-07-31 EP disclosed
EP-0703902-A4 ALBANY MOLECULAR RES INC (US) 1996-04-10 EP disclosed
EP-0703902-A1 PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION ALBANY MOLECULAR RESEARCH, INC. (US) 1996-04-03 EP disclosed
WO-1995000482-A1 PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION ALBANY MOLECULAR RESEARCH, INC. (US) 1995-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124810-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES HADHB, CPT1B, PDHB ALDH1A1 84/4885LMNA 2598/4885ALOX15 3446/4885
US-20080227983-A1 PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION HRH4, DRD4, H1-4 ALDH1A1 302/4885LMNA 4278/4885ALOX15 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.